LAM561

LAM561 · Laminar Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LAM561, covering 2023-02-21 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: LAM561 With RT and TMZ for Adults With Glioblastoma [Phase 2, Phase 3]